-+ 0.00%
-+ 0.00%
-+ 0.00%

Piper Sandler Maintains Neutral on Fulgent Genetics, Lowers Price Target to $16

Benzinga·03/04/2025 16:51:44
Listen to the news
Piper Sandler analyst David Westenberg maintains Fulgent Genetics (NASDAQ:FLGT) with a Neutral and lowers the price target from $22 to $16.